Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: J Urol. 2016 Aug 10;197(1):246–252. doi: 10.1016/j.juro.2016.07.090

Table 2.

Frequency of PPT and 24-hour urine analysis

Patients who did not complete 24-hour urine analyses (n=89) Patients who completed 24-hour urine analyses (n=196)
Citrate therapy, n (%) 6 (7) 23 (11)
Hydrochlorothiazide, n (%) 1 (1) 12 (6)
Chlorthalidone, n (%) 0 (0) 2 (1)
1 or more PPT meds, n (%) 7 (8) 35 (18)
No PPT, n (%) 82 (92) 161 (82)
Total 89 196